DecisionView Executive to Speak at Upcoming DIA Conference

Share Article

DecisionView's session, hosted by Dr. Cosimo Spera, will be held on June 25 at the annual DIA Conference in Boston. The session will focus on Advancements in Predictive Models and Algorithms for the Optimization of Clinical Trial Recruitment

Future Advancements in Models and Algorithms for the Optimization of Clinical Trial Recruitment

Past News Releases

RSS

DecisionView Inc., the leading provider of software solutions designed to improve time to market and reduce clinical trial costs for life sciences companies, confirmed that Dr. Cosimo Spera, Head of DecisionView Predictive Modeling Sciences, will be leading a session titled "Future Advancements in Models and Algorithms for the Optimization of Clinical Trial Recruitment" at the Drug Information Association annual event to be held in Boston, June 22-26, 2008. The session will be held at the Boston Convention Center on June 25, 2008 from 10:30 a.m. - 12:00.

For more than 20 years, academic researchers and practitioners have studied patient recruitment in clinical trials. While a variety of models and algorithms have been presented and discussed at a theoretical level, real world implementations have lacked success mostly because of the complexity of the proposed models and algorithms, minimal rational integration of algorithm & modeling capabilities in the enrollment business process and the difficulty in gathering relevant data required at the right time. Dr. Cosimo Spera, DecisionView, Dr. Valerii V. Fedorov, and Dr. Vladimir V. Anisimov, both with GlaxoSmithKline Pharmaceuticals, will discuss how to overcome these challenges.

About DecisionView
DecisionView develops innovative web-based software solutions that enable life sciences organizations around the world to improve clinical trial performance. DecisionView helps organizations make informed decisions by aggregating data from multiple sources and providing analytics, simulations and scenario modeling that deliver proven business value by reducing clinical trial costs and improving clinical trial predictability. Granite Ventures, Partech International and first Ventury are primary investors in the company.

Additional information about DecisionView can be found at http://www.decisionview.com/.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Stephanie Breslin
Visit website